Hong Kong · Delayed Price · Currency is HKD Kontafarma China Holdings Company Description
Kontafarma China Holdings Limited, an investment holding company, manufactures and sells chemical drugs, active pharmaceutical ingredients (API), and API intermediates in Mainland China, Singapore, Taiwan, and internationally.
The company operates through Pharmaceutical Business and Fitness Business segments. It provides prescription drugs, including chemical drugs and prescribed traditional Chinese medicines; operates fitness and yoga centers, as well as franchise business; and provides management and consultation services for fitness and health activities.
The company also provides corporate advisory services; and researches and develops medical products. The company was formerly known as Tongfang Kontafarma Holdings Limited and changed its name to Kontafarma China Holdings Limited in September 2022.
Kontafarma China Holdings Limited was incorporated in 2011 and is headquartered in Wan Chai, Hong Kong.
Kontafarma China Holdings Limited is a subsidiary of Waranty Assets Management (Hk) Limited.
| Country | Cayman Islands |
| Founded | 2011 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 636 |
| CEO | Feifei Wang |
Contact Details
Address: Sun Hung Kai Centre Wan Chai Hong Kong | |
| Phone | 852 2731 6500 |
| Website | kontafarma.com.hk |
Stock Details
| Ticker Symbol | 1312 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | HKD |
| ISIN Number | KYG8918D1088 |
| SIC Code | 3241 |
Key Executives
| Name | Position |
|---|---|
| Jie Zhang | Chief Operating Officer |
| Shouwen Ge | Vice President of Group and Executive Director |
| Lok Tung Chan | Company Secretary |
| Xuyang Han | Secretary |